Everything always seems clearer and easier to understand with the benefit of hindsight. While it seems pretty apparent now that Asian private equity would emerge as a leading asset class for investors around the world, it was actually quite difficult to imagine 12 years ago that the kind of stories we have covered in recent issues of AVCJ would be possible.
For example, I hope that most of you will have read the excellent cover story focused on placement agents in the last issue of AVCJ. For those of us that have been in the Asian private equity business...
The Everstone Group has bought a majority stake in Indian pharmaceutical developer Rubicon Research for INR2.2 billion ($32.9 million), providing an exit for Kotak Private Equity.
US-based retailer Walmart has made a $50 million strategic investment in New Dada, a Chinese online grocery and delivery platform part-owned by JD.com.
Asia Pacific Medical Group (APMG), a medical platform owned by Bain Capital, has agreed to sell Singapore and Malaysia-based plastic surgery brand The Sloane Clinic to China Medical (International) Group (CMIG).
Neobear, a China-based company that develops interactive learning tools for children, has raised a RMB250 million ($37 million) Series B round of funding led by Chinese GP New Horizon Capital.